Milestone Pharmaceuticals Inc.
MIST · NASDAQ
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2026 Q2 | August 10, 2026 | — | 1.10M | — | -0.18 | — |
| 2026 Q1 | May 13, 2026 | 238.00K | 30.12M | -0.20 | 0.06 | -9.47% |
| 2025 Q4 | March 20, 2026 | 1.50M | 37.52M | -0.16 | -0.18 | -20.00% |
| 2025 Q3 | November 12, 2025 | — | — | -0.12 | -0.17 | +1.05% |
| 2025 Q2 | August 12, 2025 | — | — | -0.20 | -0.18 | +1.19% |
| 2025 Q1 | May 14, 2025 | — | — | -0.31 | -0.19 | -0.83% |
| 2024 Q4 | March 13, 2025 | — | — | -0.19 | -0.15 | — |
| 2024 Q3 | November 12, 2024 | — | — | -0.14 | -0.16 | -3.61% |
| 2024 Q2 | August 8, 2024 | — | — | -0.14 | -0.19 | 0.00% |
| 2024 Q1 | May 13, 2024 | — | — | -0.21 | -0.26 | 0.00% |
| 2023 Q4 | March 21, 2024 | -868.00K | — | -0.32 | -0.30 | — |
| 2023 Q3 | November 13, 2023 | — | — | -0.35 | -0.38 | -1.02% |
| 2023 Q2 | August 10, 2023 | — | — | -0.37 | -0.39 | +5.77% |
| 2023 Q1 | May 11, 2023 | 1.00M | — | -0.35 | -0.38 | +3.53% |
| 2022 Q4 | March 29, 2023 | 3.50M | 1.17M | -0.31 | -0.35 | +2.87% |
| 2022 Q3 | November 10, 2022 | 1.50M | — | -0.34 | -0.41 | 0.00% |